A person posing with a certificate at ObesityWeek event, standing beside a podium displaying the event's logo.

Congrats to Dr. Kevin Williams, recipient of The Obesity Society’s inaugural Xavier Pi-Sunyer Award at ObesityWeek® #OW2025!
He co-hosts ADA’s podcast DiabetesBio and is AE for Diabetes. At UT Southwestern, his work advances understanding of brain regulation of metabolism and feeding.

Obesity The Endocrine Society works to reduce the prevalence of obesity, identify policy options to address obesity, and advocate for access to affordable care.

Read our recommended policy options we outline in our Obesity Playbook that provides the latest research on how obesity as a disease is impacting public health at staggering rates: https://bit.ly/3y2dTnL #OW2025

GLP-1 Agonists Tied to Lower Risk of Death in Dialysis Patients Use was also linked to a higher likelihood of being waitlisted for kidney transplant

Use of GLP-1 receptor agonists was associated with a lower risk of mortality for dialysis patients with type 2 diabetes, according to a retrospective cohort study of Medicare enrollees.

Read more from our coverage of #OW2025:
www.medpagetoday.com/meetingcoverage/obesityw...

Our #Obesity Special Interest Group provides a venue for members to discuss the latest breakthroughs and advances. Visit booth 627 at #OW2025 to learn about our webinars that cover topics like anti-obesity medications and the treatment landscape: https://bit.ly/3AhecA1 @obesitysociety.bsky.social

Obesity The Endocrine Society works to reduce the prevalence of obesity, identify policy options to address obesity, and advocate for access to affordable care.

14.7 million children are affected by this obesity in the US. Access additional statistics in the latest version of Obesity Playbook: https://bit.ly/3y2dTnL #OW2025 #obesity @obesitysociety.bsky.social

Important new paper just published and presented at #OW2025: The Identification of Potential Treatment Targets to Reduce the Risk of Obesity-Related Complications: A Step Toward a Treat-to-Target Approach in Obesity Management

onlinelibrary.wiley.com/doi/10.1002/...

@Busetto_Luca @AbdTahrani

Eloralintide moves the needle for Amylin agonism #weightloss #obesity in P2 trials investor.lilly.com/news-release... #OW2025

Obesity The Endocrine Society works to reduce the prevalence of obesity, identify policy options to address obesity, and advocate for access to affordable care.

Review an adult obesity prevalence map for 48 states in our Obesity Facts and Figures Statistics Flyer. This map reflects the latest data collected by the CDC on the proportion of adults with a body mass index greater than or equal to 30: https://bit.ly/3y2dTnL #OW2025 @obesitysociety.bsky.social

Don't miss this live webinar TONIGHT at 7:00 PM ET taking place during #OW2025!

Join here: event.arraylive.com/app/login/0d...

@obesitysociety.bsky.social

Membership Learn more about becoming a member of the Endocrine Society and ensure your connection with an international body of more than 18,000 motivated researchers and practitioners from over 120 countries.

Visit our booth to find out if you are eligible for 35% off membership. Gain a suite of benefits like obesity-related education, journals, and more when you become a member at booth 627 at #OW2025: https://bit.ly/31IKAnH #obesity @obesitysociety.bsky.social

Focus on Obesity The Society works to reduce prevalence of obesity. Explore our statements, guidelines, resources, and more.

Our Focus on Obesity page highlights recent webinars, clinical practice guidelines, and the latest obesity education. Global #obesity is on the rise, and endocrinologists are at the forefront of diagnosing and prescribing treatment plans. Learn more: https://bit.ly/3yV6Ihc #OW2025

Meet The Professor 2025 Book (includes ebook) Endocrine Case Management: Meet the Professor 2025 provides physicians with a concise and clinically relevant review of more than 40 endocrine disorders. The material is presented through case-based v...

Our #OW2025 staff at booth 627 will pair you with resources like Endocrine Case Management: Meet the Professor 2025 (https://bit.ly/45pXidN or our ENDO 2025 session recordings (https://bit.ly/47FiT4W that offer the latest advancements in obesity. @obesitysociety.bsky.social

Obesity The Endocrine Society works to reduce the prevalence of obesity, identify policy options to address obesity, and advocate for access to affordable care.

Discover the estimated $1.5 billion annual cost of obesity-related health care that the US Department of Defense grapples with. Our Obesity Playbook outlines considerations and legislation pertaining to obesity treatment in the US: https://bit.ly/3y2dTnL #OW2025 @obesitysociety.bsky.social

Obesity and Appetite Regulation Browse articles, products, and services related to obesity and appetite regulation.

We are exhibiting at #OW2025 booth 627! The Society is a proven leader in the obesity space as one of the medical societies that successfully called for AMA to name #obesity a chronic disease. Stop by to receive our obesity-related education: bit.ly/2TEgXlj @obesitysociety.bsky.social

Why do people have trouble losing weight in 2025? Well there's a few reasons. We live in a time of abundance and convenience. We've created an environment where our body's regulators become overwhelmed and we gain weight. #OW2025

Obesity is a chronic condition that is often misunderstood. To watch the full version of this video, click here badgut.org/obesity-jour...

#OW2025 #diet #health #awareness #bmi #weight #weightloss #obesity #hunger #weightgain #metabolism

This one is for #Nephsky from #OW2025 outcomes in dialysis patients starting GLP1 medications specifically looking at wait listing for transplant and for mortality reductions so what did they find? They used renal data from Medicare claims to examine this

Attending #ObesityWeek #OW2025 in Atlanta this week? Stop by the welcome booth at registration when you arrive. Lots of fun things will be happening here today for TOS members!

Don't miss this CE dinner TOMORROW at 6:30 PM ET during #OW2025 or virtually: events.vindicocme.com/en/15kYU86/g...

@obesitysociety.bsky.social

My #OW2025 schedule today, Slightly overbooked but, liver and kidney disease to start then neurobiology, dose de-escalation for maintenance, then NA-931(which is a scam/fake drug?!! More on that later) and finally finish with cancer and obesity and finish with poster session.

Can't make it to Atlanta for #OW2025?

Join us virtually on Wednesday at 7:00 PM ET for an engaging CE webinar that explores obesity pathophysiology: events.vindicocme.com/en/15kYU86/g...

@obesitysociety.bsky.social

#OW2025 so excited for the next few days!

Join us at #OW2025 on 11/5 for the Amylin Adventure, an interactive program exploring amylin’s role alongside key regulatory hormones like GLP-1, glucagon, and GIP: events.vindicocme.com/en/15kYU86/g...

@obesitysociety.bsky.social

Register today to join us virtually for "The Amylin Adventure: Exploring Amylin-Based Therapies for Obesity Management" taking place during #OW2025 on 11/5: events.vindicocme.com/en/15kYU86/g...

@obesitysociety.bsky.social

Are you heading to #OW2025? Join us for the Amylin Adventure #CE Dinner symposium.

More Info: events.vindicocme.com/en/15kYU86/g...

@obesitysociety.bsky.social

Attendees of this CE dinner symposium at #OW2025 will receive an organ plushie and collect printed resources highlighting key regulatory hormones in obesity!

Don't miss it: events.vindicocme.com/en/15kYU86/g...

@obesitysociety.bsky.social